Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas
- PMID: 2023282
- DOI: 10.1093/jnci/83.9.640
Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas
Erratum in
- J Natl Cancer Inst 1991 Jun 19;83(12):881
Abstract
Gastric cancer can be divided into two histologic types: intestinal and diffuse. To determine whether Helicobacter pylori, a bacterium linked with gastritis, was associated with either cancer type, we reviewed histologic sections from stomachs of patients who had undergone gastrectomy for gastric cancer. Of 37 of the sections with evidence of intestinal-type cancer, 33 (89.2%) contained H pylori in noncancerous tissue compared with 7 (31.8%) of 22 of the sections with evidence of diffuse-type cancer (odds ratio = 17.7; P less than .001). This association remained strong when controlled for age, sex, site, and number of sections reviewed. The prevalence of H pylori in intestinal-type gastric cancer far exceeded the prevalence of H pylori in diffuse disease and that described in the normal US population. This finding suggests that H pylori may be a cofactor in development of intestinal-type gastric cancer.
Similar articles
-
Association of Helicobacter pylori with carcinoma of stomach.J Pak Med Assoc. 2007 Jul;57(7):337-41. J Pak Med Assoc. 2007. PMID: 17867254
-
Prevalence of Helicobacter pylori infection in advanced gastric carcinoma.Arq Gastroenterol. 2006 Oct-Dec;43(4):288-92. doi: 10.1590/s0004-28032006000400009. Arq Gastroenterol. 2006. PMID: 17406757 Clinical Trial.
-
[Helicobacter pylori and gastric cancer. The incidence of infection in personal experience].Minerva Chir. 2002 Oct;57(5):649-55. Minerva Chir. 2002. PMID: 12370666 Review. Italian.
-
Gastric cancer and Helicobacter pylori infection.Br J Surg. 1993 Mar;80(3):378-9. doi: 10.1002/bjs.1800800339. Br J Surg. 1993. PMID: 8472158
-
Review article: Helicobacter pylori and gastric adenocarcinoma.Aliment Pharmacol Ther. 2002 Mar;16 Suppl 1:40-6. doi: 10.1046/j.1365-2036.2002.0160s1040.x. Aliment Pharmacol Ther. 2002. PMID: 11849127 Review.
Cited by
-
Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review.Vaccines (Basel). 2022 Oct 16;10(10):1727. doi: 10.3390/vaccines10101727. Vaccines (Basel). 2022. PMID: 36298592 Free PMC article. Review.
-
Different Incidence of Early-Onset Gastric Carcinoma Depending on Ethnicity: Preliminary Results of a Hospital in Liangshan.ScientificWorldJournal. 2020 Mar 10;2020:6845413. doi: 10.1155/2020/6845413. eCollection 2020. ScientificWorldJournal. 2020. PMID: 32231466 Free PMC article.
-
A population-based comparison of patients with metastatic esophagogastric carcinoma between Japan and the Netherlands.J Cancer Res Clin Oncol. 2023 Nov;149(14):13323-13330. doi: 10.1007/s00432-023-05111-4. Epub 2023 Jul 24. J Cancer Res Clin Oncol. 2023. PMID: 37486395 Free PMC article.
-
The British Society of Gastroenterology Diamond Jubilee. March 1997.Gut. 1997 Mar;40 Suppl 2(Suppl 2):S1-44. doi: 10.1136/gut.40.suppl_2.s1. Gut. 1997. PMID: 9170354 Free PMC article. No abstract available.
-
Phenotypic Differences of Gastric Cancer according to the Helicobacter pylori Infection in Korean Patients.J Gastric Cancer. 2010 Dec;10(4):168-74. doi: 10.5230/jgc.2010.10.4.168. Epub 2010 Dec 31. J Gastric Cancer. 2010. PMID: 22076182 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical